Safety and efficacy of classical complement pathway inhibition with sutimlimab in chronic immune thrombocytopenia
- Resource Type
- Article
- Source
- In
Blood Advances 28 March 2023 7(6):987-996 - Subject
Platelets and Thrombopoiesis - Language
- ISSN
- 2473-9529